MicroRNA-146a and-21 cooperate to regulate vascular smooth muscle cell proliferation via modulation of the Notch signaling pathway

A number of microRNAs (miRs) have been shown to participate in the regulation of vascular smooth muscle cell (VSMC) proliferation, a key step in the formation of atherosclerotic plaque, by targeting certain genes. The aim of the present study was to investigate the roles of miR-146a and miR-21 in VSMC growth and to study the underlying mechanisms. The expression levels of four previously reported, differentially expressed microRNAs in atherosclerotic plaque (miR-146a/b, miR-21, miR-34a and miR-210) were measured in two groups: An atherosclerotic plaque group (n=10) and a normal control group (n=10). Polymerase chain reaction (PCR) analysis revealed that the relative expression levels of miR-146a and miR-21 in atherosclerotic plaque samples were significantly upregulated to similar to 260 and 250%, respectively, compared with those in normal controls. Notch2 and Jag1 were confirmed to be target genes of miR-146a and miR-21 through the use of a luciferase assay, PCR and western blot analysis. Additionally, VSMCs transfected with miR-146a expressed significantly lower levels of Notch2 protein and presented an accelerated cell proliferation, which could be attributed to a reduction in the levels of cell cycle arrest. Cotransfection of miR-146a and miR-21 further promoted cell cycle progression in addition to VSMC proliferation. In conclusion, the present study revealed that miR-146a and miR-21 were significantly upregulated in atherosclerotic plaque, and cooperated to accelerate VSMC growth and cell cycle progression by targeting Notch2 and Jag1.